Can-Fite BioPharma Ltd. Operating Lease Right-of-Use Assets
Can-Fite BioPharma Ltd. (CANF) had Operating Lease Right-of-Use Assets of $69.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-03-26
- 2025-12-31: Operating Lease, Right-of-Use Asset $69.00K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $91.00K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $111.00K.
- 2024-06-30: Operating Lease, Right-of-Use Asset $62.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $69.00K 20-F · filed 2026-03-26 |
| 2025-06-30 | $91.00K 6-K · filed 2025-08-28 |
| 2024-12-31 | $111.00K 20-F · filed 2026-03-26 |
| 2024-06-30 | $62.00K 6-K · filed 2024-08-29 |
| 2023-12-31 | $52.00K 20-F · filed 2025-04-14 |
| 2023-06-30 | $87.00K 6-K · filed 2023-08-31 |
| 2022-12-31 | $84.00K 20-F · filed 2024-03-28 |
| 2022-06-30 | $111.00K 6-K · filed 2022-08-25 |
| 2021-12-31 | $138.00K 20-F · filed 2023-03-30 |
| 2021-06-30 | $77.00K 6-K · filed 2021-08-26 |
| 2020-12-31 | $73.00K 20-F · filed 2022-03-24 |
| 2020-06-30 | $66.00K 6-K · filed 2020-08-27 |
| 2019-12-31 | $82.00K 20-F · filed 2021-03-25 |